Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Neal

Showing results (81-90 of 302) with videos related to

Pageof 31
Sort By:
BMC Research Notes|October 3, 2015
Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomyTobias Janowitz, Sarah Welsh, Anne Y Warren, et al.
BMC Family Practice|June 3, 2014
The importance of dietary change for men diagnosed with and at risk of prostate cancer: a multi-centre interview study with men, their partners and health professionalsKerry N L Avery, Jenny L Donovan, Jeremy Horwood, et al.
EMBO Reports|August 28, 2007
New androgen receptor genomic targets show an interaction with the ETS1 transcription factorCharles E Massie, Boris Adryan, Nuno L Barbosa-Morais, et al.
Cancer Causes & Control : CCC|December 11, 2012
Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT studyAnya Burton, Richard M Martin, Jeff Holly, et al.
Trials|October 15, 2016
Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trialEleanor I Walsh, Emma L Turner, J Athene Lane, et al.
BJU International|August 20, 2008
Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?Kerry N L Avery, Chris Metcalfe, Jane M Blazeby, et al.
Urologic Oncology|December 17, 2014
Surgical margin length and location affect recurrence rates after robotic prostatectomyHarveer S Dev, Peter Wiklund, Vipul Patel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2009
Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) studySimon M Collin, Chris Metcalfe, Jenny L Donovan, et al.
Cancer Causes & Control : CCC|March 3, 2012
Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the prostate testing for cancer and treatment studyRebecca Gilbert, Richard M Martin, William D Fraser, et al.
BMC Medical Genomics|May 21, 2008
Pro-neural transcription factors as cancer markersMaria Vias, Charlie E Massie, Philip East, et al.
Pageof 31

Showing results (81-90 of 302) with videos related to

Sort By:
Pageof 31
BMC Research Notes|October 3, 2015
Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomyTobias Janowitz, Sarah Welsh, Anne Y Warren, et al.
BMC Family Practice|June 3, 2014
The importance of dietary change for men diagnosed with and at risk of prostate cancer: a multi-centre interview study with men, their partners and health professionalsKerry N L Avery, Jenny L Donovan, Jeremy Horwood, et al.
EMBO Reports|August 28, 2007
New androgen receptor genomic targets show an interaction with the ETS1 transcription factorCharles E Massie, Boris Adryan, Nuno L Barbosa-Morais, et al.
Cancer Causes & Control : CCC|December 11, 2012
Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT studyAnya Burton, Richard M Martin, Jeff Holly, et al.
Trials|October 15, 2016
Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trialEleanor I Walsh, Emma L Turner, J Athene Lane, et al.
BJU International|August 20, 2008
Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?Kerry N L Avery, Chris Metcalfe, Jane M Blazeby, et al.
Urologic Oncology|December 17, 2014
Surgical margin length and location affect recurrence rates after robotic prostatectomyHarveer S Dev, Peter Wiklund, Vipul Patel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2009
Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) studySimon M Collin, Chris Metcalfe, Jenny L Donovan, et al.
Cancer Causes & Control : CCC|March 3, 2012
Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the prostate testing for cancer and treatment studyRebecca Gilbert, Richard M Martin, William D Fraser, et al.
BMC Medical Genomics|May 21, 2008
Pro-neural transcription factors as cancer markersMaria Vias, Charlie E Massie, Philip East, et al.
Pageof 31